Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Clinical Data Analytics Solutions Market

Clinical Data Analytics Solutions Market Trends

Report ID: GMI9275
Published Date: Apr 2024
Report Format: PDF

Download Free Sample

Clinical Data Analytics Solutions Market Trends

Growing focus on personalized medicine, precision health interventions, and targeted therapies is driving the integration of genomics data with clinical data analytics solutions. As a result, the vendors are increasingly prioritizing such integration to enable more comprehensive patient profiling, predictive modeling, and treatment optimization, and to offer cutting edge clinical data analytical solutions in the market.
Vendors are also focusing towards exploring blockchain technology in healthcare to strengthen data security, integrity, and traceability in clinical data analytics, to ensure secure sharing and access of sensitive healthcare data.
Growing demand for cost optimization has led the healthcare organizations to invest heavily on clinical data analytics solutions to bolster value-based care models and promote performance evaluation, and reimbursement optimization based on clinical results and patient satisfaction.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Clinical data analytics solutions market size was valued at USD 5.9 billion in 2023 and is anticipated to showcase 12.8% CAGR from 2024 – 2032, owing to increasing adoption of electronic health records (EHRs) and the rising demand for real-time data insights to enhance patient outcomes.

The pharmaceutical and biotechnology companies segment in the clinical data analytics solutions industry is anticipated to grow at 13% CAGR during 2024-2032, driven by increasing adoption to optimize trial design, streamline recruitment processes, and identify suitable patient populations.

North America clinical data analytics solutions market accounted for 63.4% share and is predicted to reach USD 11.1 billion by 2032, attributed to increasing number of drug approvals by the regulatory organizations such as the U.S. Food and Drug Administration (FDA).

Allscripts Healthcare Solutions, Inc., CareCloud Corporation, Cerner Corporation, Dassault Systèmes, eClinical Solutions LLC, Inspirata Inc., IQVIA Inc., Medeanalytics, Inc., Medical Information Technology Inc., Optum, Inc., Oracle Corporation, Qsi Management LLC, SAS Institute, Inc., Truven Health Analytics, Inc. and Verisk Analytics, Inc.